Real Estate -
REIT - Healthcare Facilities - NASDAQ - US
$ 16.47
-4.69 %
$ 3.92 B
Market Cap
30.5
P/E
1. INTRINSIC VALUE
Balance Sheet
Sabra Health Care REIT, Inc.
| Current Assets | 192 M |
| Cash & Short-Term Investments | 60.5 M |
| Receivables | 132 M |
| Other Current Assets | 0 |
| Non-Current Assets | 4.72 B |
| Long-Term Investments | 183 M |
| PP&E | 0 |
| Other Non-Current Assets | 4.54 B |
| Current Liabilities | 1.76 B |
| Accounts Payable | 0 |
| Short-Term Debt | 1.76 B |
| Other Current Liabilities | 0 |
| Non-Current Liabilities | 800 M |
| Long-Term Debt | 26.8 M |
| Other Non-Current Liabilities | 773 M |
EFFICIENCY
Earnings Waterfall
Sabra Health Care REIT, Inc.
| Revenue | 703 M |
| Cost Of Revenue | 227 M |
| Gross Profit | 476 M |
| Operating Expenses | 476 M |
| Operating Income | 0 |
| Other Expenses | -127 M |
| Net Income | 127 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Sabra Health Care REIT, Inc.
| Net Income | 127 M |
| Depreciation & Amortization | 170 M |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 8.99 M |
| Change in Working Capital | 0 |
| Others | 5.22 M |
| Free Cash Flow | 311 M |
Wall Street Analysts Price Targets
Sabra Health Care REIT, Inc.
Wall Street analysts predict an average 1-year price target for SBRA of $17.2 , with forecasts ranging from
a
low of
$15 to a high of $20 .
SBRA Lowest Price Target
Wall Street Target
15 USD
-8.93%
SBRA Average Price Target
Wall Street Target
17.2 USD
4.74%
SBRA Highest Price Target
Wall Street Target
20 USD
21.43%
4. DIVIDEND
ANALYSIS
1.73%
DIVIDEND YIELD
0.3 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Sabra Health Care REIT, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
147 K USD 1
Bought
40.3 K USD 1
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
101 K USD 1
9-12 MONTHS
7. News
Sabra Health Care REIT, Inc. Announces Chief Investment Officer Transition
TUSTIN, Calif.--(BUSINESS WIRE)---- $CIO #CIO--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Talya Nevo-Hacohen, Sabra's Chief Investment Officer, Treasurer and Executive Vice President, has decided to retire effective December 31, 2025 and Darrin Smith, Sabra's Executive Vice President, Investments, is expected to be elevated to the role of Sabra's Chief Investment Officer effective January 1, 2026. Ms. Nevo-Hacohen is expected to remain in a consulting role with Sabra pursuant.
businesswire.com
- 4 weeks ago
Sabra Health Care REIT: Come For Income, Stay For Growth
Sabra Health Care REIT, Inc. offers a 6.7% dividend yield, benefiting from strong fundamentals, favorable demographics, and a well-managed balance sheet. Management is guiding for AFFO growth, supported by rising occupancy, stable reimbursement rates, and a robust acquisition pipeline in skilled nursing. SBRA stock trades at a reasonable valuation with a forward P/FFO of 12.2, positioning it for potential market-beating total returns.
seekingalpha.com
- 1 month ago
7 Stocks I'm Buying As The U.S. Economy Starts To Crack
I emphasize the importance of nonpartisan economic and investment analysis, highlighting how political biases can distort market expectations and investment decisions. Medicaid cuts would likely have little impact on skilled nursing facility REITs, and the current selloff presents a buying opportunity for CareTrust REIT. Single-family rental REITs face challenges from high home prices and mortgage rates, but offer quality rental homes and professional management.
seekingalpha.com
- 1 month ago
Sabra Health Care REIT, Inc. (SBRA) Q4 2024 Earnings Call Transcript
Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q4 2024 Earnings Conference Call February 20, 2025 1:00 PM ET Company Participants Lukas Hartwich - EVP, Finance Rick Matros - CEO, President & Chair Talya Nevo-Hacohen - CIO, Treasurer & EVP Mike Costa - CFO Conference Call Participants Farrell Granath - Bank of America John Kilichowski - Wells Fargo Michael Griffin - Citi Research Austin Wurschmidt - KeyBanc Capital Markets Georgi Dinkov - Mizuho Juan Sanabria - BMO Capital Markets Richard Anderson - Wedbush Alec Feygin - Baird Equity Research Michael Stroyeck - Green Street Aaron Hecht - JMP Securities Omotayo Okusanya - Deutsche Bank Operator Good day. My name is Aaron, and I will be your conference operator for today.
seekingalpha.com
- 1 month ago
Sabra (SBRA) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zacks.com
- 1 month ago
Sabra Healthcare (SBRA) Q4 FFO Match Estimates
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.36 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.33 per share a year ago.
zacks.com
- 1 month ago
Sabra Reports Fourth Quarter 2024 Results; Introduces 2025 Guidance
TUSTIN, Calif.--(BUSINESS WIRE)-- #4Q24--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2024. FOURTH QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2024 were as follows: Net Income: $0.19 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.09x Senior Housing - Leased: 1.36x Beh.
businesswire.com
- 1 month ago
Sabra Health Care REIT, Inc. Announces Leadership Promotions
TUSTIN, Calif.--(BUSINESS WIRE)-- #LEADERSHIP--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced three promotions within its leadership team. Lukas Hartwich has been promoted to Executive Vice President – Finance after previously serving as Senior Vice President – Finance. Since joining Sabra in October 2021, Mr. Hartwich has made notable contributions across the organization, including through his leadership of Sabra's financial planning and analysis, investor rela.
businesswire.com
- 2 months ago
Gear Up for Sabra (SBRA) Q4 Earnings: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Sabra (SBRA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
zacks.com
- 2 months ago
Sabra Health Care REIT, Inc. Announces Fourth Quarter 2024 Earnings Release Date and Conference Call; Declares Common Dividend
TUSTIN, Calif.--(BUSINESS WIRE)-- #4Q24--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2024 fourth quarter earnings release on February 19, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 fourth quarter results will be held on Thursday, February 20 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conferen.
businesswire.com
- 2 months ago
Jefferies Loves 5 High-Yield Healthcare REITs in 2025 for Growth and Income
While the December interest rate cut of 25 basis points may be the last for a while, it is an excellent bet that federal funds will be lower than today's effective rate of 4.23%, and below the long-term average of 4.61%.
247wallst.com
- 2 months ago
Sabra Health Care REIT, Inc. Announces Tax Treatment of 2024 Distributions
TUSTIN, Calif.--(BUSINESS WIRE)-- #dividends--Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today the tax treatment for its 2024 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid: Sabra Health Care REIT, Inc. Common Stock (CUSIP # 78573L106) Record Date Payable Date Distribution per Share Total Ordinary Dividends Non-Qualified Dividends Qualified Dividends Non-Dividend Distributions 02/13/2024 02/29/2024 $ 0.3000000 $ 0.2649.
businesswire.com
- 2 months ago
8. Profile
Summary
Sabra Health Care REIT, Inc. SBRA
COUNTRY
US
INDUSTRY
REIT - Healthcare Facilities
MARKET CAP
$ 3.92 B
Dividend Yield
1.73%
Description
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.
Contact
18500 Von Karman Avenue, Irvine, CA, 92612
https://www.sabrahealth.com
IPO
Date
April 2, 2002
Employees
50
Officers
Mr. Richard K. Matros
Chairman, President & Chief Executive Officer
Ms. Kara Pappanduros
Senior Vice President of Asset Management
Ms. Jessica Flores
Executive Vice President, Chief Accounting Officer & Principal Accounting officer
Ms. Talya Nevo-Hacohen
Executive Vice President, Chief Investment Officer & Treasurer
Mr. Darrin L. Smith
Executive Vice President of Investments
Mr. Peter W. Nyland
Executive Vice President of Asset Management
Ms. Eliza Gozar
Senior Vice President of Investments
Mr. Michael Lourenco Costa CPA
Executive Vice President, Chief Financial Officer & Secretary
Mr. Lukas Michael Hartwich C.F.A.
Executive Vice President of Finance